MBX Biosciences, Inc. (MBX) Form 10-K Annual Reports
MBX Biosciences, Inc. (MBX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MBX
CIK: 1776111
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerRobert Hofinger
Audit LocationIndianapolis, Indiana, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-08-27 | 2026-08-27 | 8-K | 0001193125-26-369674 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001959173-26-006112 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003482 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-10 | — | SCHEDULE 13D/A Filing | 0001231919-26-000851 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-10 | — | SCHEDULE 13D/A Filing | 0000947871-26-000776 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-336849 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-336841 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-04 | 4 | 0001193125-26-335373 | View SEC Doc Filr Page |
| 144 | 2026-08-04 | — | 144 Filing | 0001959173-26-005629 | View SEC Doc Filr Page |
| 144 | 2026-08-04 | — | 144 Filing | 0001959173-26-005628 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-03 | 4 | 0001193125-26-331642 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-03 | 4 | 0001193125-26-331639 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0002012383-26-002818 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-09 | 8-K | 0001193125-26-302098 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0000902219-26-000214 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0000315066-26-001474 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-24 | — | SCHEDULE 13G Filing | 0001104659-26-077301 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-12 | 8-K | 0001193125-26-268477 | View SEC Doc Filr Page |
| 144 | 2026-06-10 | — | 144 Filing | 0001959173-26-004511 | View SEC Doc Filr Page |
| 144 | 2026-06-09 | — | 144 Filing | 0001959173-26-004487 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-259236 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-258436 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-258435 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-258432 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-258429 | View SEC Doc Filr Page |